2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
440
Rectal Neoplasms
209
Colonic Neoplasms
202
Pancreatic Neoplasms
131
Stomach Neoplasms
117
Neoplasm Metastasis
97
Neoplasms
64
Esophageal Neoplasms
57
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Lymphoma
49
Leukemia
41
Carcinoma, Hepatocellular
41
Adenocarcinoma Of Esophagus
37
Burkitt Lymphoma
33
Adenocarcinoma
29
Cholangiocarcinoma
26
Biliary Tract Neoplasms
23
Carcinoma, Non-Small-Cell Lung
21
Gastrointestinal Neoplasms
20
Gallbladder Neoplasms
20
Lymphoma, Non-Hodgkin
19
Esophageal Squamous Cell Carcinoma
15
Osteosarcoma
14
Liver Neoplasms
14
Bile Duct Neoplasms
14
Unspecified Adult Solid Tumor, Protocol Specific
13
Lymphoma, Large B-Cell, Diffuse
13
Leukemia, Biphenotypic, Acute
13
Ovarian Neoplasms
12
Leukemia, Myeloid, Acute
12
Interventions
Cisplatin
180
Radiotherapy
81
Paclitaxel
80
Brachytherapy
74
Carboplatin
72
pembrolizumab
63
Bevacizumab
40
Surveys and Questionnaires
29
Colposcopy
29
Radiation
28
Gemcitabine
28
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
27
Topotecan
26
Magnetic Resonance Spectroscopy
24
Blood Specimen Collection
23
human papillomavirus vaccine, L1 type 16, 18
22
Nivolumab
22
Drug Therapy
21
Papillomavirus Vaccines
20
atezolizumab
19
Platinum
19
Radiotherapy, Intensity-Modulated
18
Biopsy
18
Docetaxel
17
Taxes
16
Cyclophosphamide
16
Early Intervention, Educational
15
1,2-diaminocyclohexaneplatinum II citrate
15
Methods
14
fludarabine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Leucovorin
×
Clear all
NCT05891171
2026-03-31
ARC-25
Arcus Biosciences, Inc.
Phase 1
Active not recruiting
40 enrolled